InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,463.54
(
0.08%
)
US TECH 100
18,562.80
(
0.04%
)
Dow Jones
40,539.93
(
-0.12%
)
Brent Oil
79.09
(
-0.07%
)
Bitcoin
66,851.29
(
0.04%
)
Post# of 252727
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

semi_infinite

Send PM Follow Ignore
Followers 14
Posts 3823
Boards Moderated 1
Alias Born 07/07/2002

semi_infinite

Re: DewDiligence post# 215443

Monday, 11/27/2017 1:46:03 PM

Monday, November 27, 2017 1:46:03 PM

Post# of 252727
Is increasing N from 2000 to 2370 an indication of over enrollment or requested by the FDA IYO? It could explain why the evaluation period is lengthened by 1 year, but it seems that stats delta going from 2000 to 2370 can't be significant. Any implications for the length of time required for ENTA's trial?

Note - they also added measurement of Conjugated bilirubin to the list of things being monitored.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up